Paurus M. Irani
Tadworth, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Effectiveness and safety of ceftazidime-avibactam in Chinese patients with hospital-acquired pneumonia, including ventilator-associated pneumonia: A Phase 4, multi-centre, open-label study.
Journal: Journal of global antimicrobial resistance
Published: December 17, 2024
Pharmacokinetics and Safety of Ceftazidime-Avibactam in Neonates and Young Infants: A Phase 2a, Multicenter Prospective Trial.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: October 24, 2024
Correction to: Ceftazidime‑Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta‑analysis.
Journal: Infectious diseases and therapy
Published: August 28, 2024
Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis.
Journal: Infectious diseases and therapy
Published: November 15, 2023
The Use and Effectiveness of Ceftazidime-Avibactam in Real-World Clinical Practice: EZTEAM Study.
Journal: Infectious diseases and therapy
Published: July 05, 2022
Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programme.
Journal: The Journal of antimicrobial chemotherapy
Published: September 21, 2021
Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas aeruginosa.
Journal: Antibiotics (Basel, Switzerland)
Published: July 09, 2021
In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017-2019.
Journal: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
Published: June 28, 2021
Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review.
Journal: Infectious diseases and therapy
Published: January 14, 2021
Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program.
Journal: Infectious diseases and therapy
Published: December 23, 2020
Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy.
Journal: Clinical therapeutics
Published: November 11, 2019
Last Updated: 09/26/2026